CEMIP and neoplasm: To investigate the clinical role of KIAA1199 in GC, we assessed the correlations between KIAA1199 expression and clinicopathological parameters, including sex, depth of invasion (T-staging), lymph node status, distant metastasis (M-staging), TNM staging, tumor differentiation and clinical outcome of GC patients.